OCM
PFE icon

Orser Capital Management’s Pfizer PFE Stock Holding History

Orser Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-56,640
Closed -$2.08M – 95
2020
Q4 		$2.08M Buy
56,640
+44,667
+373% +$1.64M 1.32% 31
2020
Q3 		$417K Buy
11,973
+316
+3% +$11.1K 0.33% 56
2020
Q2 		$362K Buy
11,657
+464
+4% +$15.8K 0.33% 49
2020
Q1 		$347K Sell
11,193
-390
-3% -$13.3K 0.49% 41
2019
Q4 		$428K Buy
11,583
+305
+3% +$10.9K 0.41% 52
2019
Q3 		$390K Sell
11,278
-21,722
-66% -$790K 0.46% 47
2019
Q2 		$1.42M Sell
33,000
-1,465
-4% -$58.2K 1.46% 27
2019
Q1 		$1.39M Buy
34,465
+1,465
+4% +$58.7K 1.53% 27
2018
Q4 		$1.38M Hold
33,000
– – 1.59% 34
2018
Q3 		$1.38M Hold
33,000
– – 1.32% 38
2018
Q2 		$1.17M Buy
33,000
+15,357
+87% +$525K 1.02% 41
2018
Q1 		$585K Buy
17,643
+1,159
+7% +$39.8K 0.54% 59
2017
Q4 		$574K Buy
+16,484
New +$562K 0.51% 67

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Orser Capital Management's PFE Position: Q1 2021 in Review

Orser Capital Management sold out of Pfizer (PFE) in Q1 2021, closing a stake of 56,640 shares — an estimated $2.08M sold.

Orser Capital Management first reported a position in PFE in Q4 2017 and held it in 13 quarters. The position peaked at $2.08M in Q4 2020. 2,676 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

  • Orser Capital Management reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
  • Orser Capital Management sold 56,640 Pfizer shares in Q1 2021, an estimated $2.08M.
  • Orser Capital Management first reported a position in Pfizer in Q4 2017 and held it in 13 quarters.
  • Orser Capital Management's Pfizer position peaked at $2.08M in Q4 2020.
  • 2,676 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Orser Capital Management's 13F filing for Q1 2021, filed 10 May 2021.